Auris Medical Holding Ltd

EARS:NASDAQ
RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 11:19 AM EST
2.94quote price arrow up+0.06 (+2.08%)
Volume
153,799
52 week range
0.65 - 6.60

...

Loading . . .

KEY STATS

  • Open2.86
  • Day High2.96
  • Day Low2.85
  • Prev Close2.88
  • 52 Week High6.60
  • 52 Week High Date12/01/20
  • 52 Week Low0.65
  • 52 Week Low Date03/17/20
  • Market Cap38.75M
  • Shares Out13.18M
  • 10 Day Average Volume2.10M
  • Dividend-
  • Dividend Yield-
  • Beta1.18
  • 1 Year % Change104.23

RATIOS/PROFITABILITY

  • EPS (TTM)-2.36
  • P/E (TTM)-1.25
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-6.24M
  • ROE (MRQ)-84.67%
  • Revenue (MRQ)0.00M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)1.12%

EVENTS

  • Earnings Date03/14/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Auris Medical Holding Ltd News

There is no recent news for this security.

Latest EARS News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Auris Medical Holding AG is a Switzerland-based biotechnology company engaged in developing pharmaceutical products for the treatment of inner ear disorders and mental health supportive care. The Company focuses on the development of intranasal betahistine for the treatment of vertigo (AM-125) and for the treatment of antipsychotic-induced weight gain and somnolence (AM-201). The betahistine program is in Phase 1 of clinical trials. Other programs in the Company's product...
Address
Bahnhofstrasse 21
Zug, ZUG
6300
Switzerland